July 30, 2021 - ROSEN LOGO.jpg
SBTX SHAREHOLDER ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Silverback Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SBTX
November 10, 2021 14:22 ET | The Rosen Law Firm PA
NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
22157.jpg
Global Oncology Based In-vivo CRO Markets to 2028 by Indication (Blood Cancer, Solid Tumor), Model (Syngeneic Model, Patient Derived Xenograft (PDX), Xenograft),
October 15, 2021 05:08 ET | Research and Markets
Dublin, Oct. 15, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Based In-vivo CRO Market Size, Share & Trends Analysis Report by Indication (Blood Cancer, Solid Tumor), by Model (Syngeneic Model,...
TIP_link_300x300.jpg
Neoantigens Market Size ($10,54,783.54 Thousand by 2028) Growth Forecast at 31.2% CAGR During 2023 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
October 07, 2021 10:16 ET | The Insight Partners
New York, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Neoantigens Market: Key InsightsAccording to our new research study on “Neoantigens Market to 2028 – Global Analysis and Forecast – by Treatment and...
Logo.jpg
INVECTYS INC. TO PARTICIPATE IN THE 2021 H.C. WAINWRIGHT 23rd ANNUAL GLOBAL INVESTMENT CONFERENCE SEPTEMBER 13-15, 2021
September 07, 2021 09:00 ET | Invectys, Inc.
Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of products...
22157.jpg
PD-1 Resistant Head and Neck Cancer (HNC) Market Landscape Report 2021
August 31, 2021 04:08 ET | Research and Markets
Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "PD-1 Resistant Head and Neck Cancer (HNC) - Market Insight, Epidemiology and Market Forecast 2030" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Oncology Based In-Vivo CRO Markets, 2021-2027: Focus on Solid Tumors, Blood Cancer, Other Indications
July 27, 2021 08:08 ET | Research and Markets
Dublin, July 27, 2021 (GLOBE NEWSWIRE) -- The "Oncology Based In-Vivo CRO - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Oncology...
22157.jpg
Global $3.32 Bn Interventional Oncology Devices Market to 2030: Embolization Devices, Ablation Devices, & Support Devices
July 16, 2021 05:53 ET | Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
Atyr_Logo.png
aTyr Pharma Presents Preclinical Research Highlighting Mechanistic Insights into Tumor Inhibitory Effects of ATYR2810
May 19, 2021 08:00 ET | aTyr Pharma, Inc.
SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
22157.jpg
Oncology Information System Market by Software, Application and End-user - Global Forecast to 2025
March 02, 2021 07:18 ET | Research and Markets
Dublin, March 02, 2021 (GLOBE NEWSWIRE) -- The "Oncology Information System Market by Software (Patient Information System, TPS, RIS, PACS, Services), Application (Medical, Radiation, Surgical...
22157.jpg
Global Oncology Bispecific CD3 Molecules Analytical Tool 2021: 67 Companies Plus Partners who are Today Developing 148 Drugs, 127 are in Active Development in Cancer Across 63 Different Targets
January 26, 2021 04:28 ET | Research and Markets
Dublin, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The "Bispecific CD3 Molecules in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. There is a considerable and robust...